Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

TVGN Tevogen Bio Holdings Inc.

Price (delayed)

$1.3

Market cap

$239.06M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.2

Enterprise value

$241.91M

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN ...

Highlights
The company's quick ratio has surged by 50% QoQ and by 41% YoY
The EPS has plunged by 186% from the previous quarter but it has grown by 26% YoY
The debt has soared by 132% YoY and by 67% from the previous quarter
The net income has dropped by 66% year-on-year

Key stats

What are the main financial stats of TVGN
Market
Shares outstanding
183.89M
Market cap
$239.06M
Enterprise value
$241.91M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$34.4M
Net income
-$31.9M
EBIT
-$31.85M
EBITDA
-$31.43M
Free cash flow
-$13.14M
Per share
EPS
-$0.2
EPS diluted
-$0.2
Free cash flow per share
-$0.08
Book value per share
-$0.04
Revenue per share
$0
TBVPS
$0.03
Balance sheet
Total assets
$4.07M
Total liabilities
$11.79M
Debt
$4.82M
Equity
-$7.72M
Working capital
-$5.64M
Liquidity
Debt to equity
-0.62
Current ratio
0.35
Quick ratio
0.24
Net debt/EBITDA
-0.09
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-843.1%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TVGN stock price

How has the Tevogen Bio Holdings stock price performed over time
Intraday
1.56%
1 week
-0.76%
1 month
28.71%
1 year
65.67%
YTD
26.21%
QTD
20.37%

Financial performance

How have Tevogen Bio Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$34.4M
Net income
-$31.9M
Gross margin
N/A
Net margin
N/A
The net income has dropped by 66% year-on-year
The operating income has increased by 44% since the previous quarter and by 21% year-on-year

Price vs fundamentals

How does TVGN's price correlate with its fundamentals

Growth

What is Tevogen Bio Holdings's growth rate over time

Valuation

What is Tevogen Bio Holdings stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has plunged by 186% from the previous quarter but it has grown by 26% YoY
Tevogen Bio Holdings's equity has decreased by 33% YoY and by 16% QoQ

Efficiency

How efficient is Tevogen Bio Holdings business performance
The return on assets has dropped by 196% since the previous quarter

Dividends

What is TVGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TVGN.

Financial health

How did Tevogen Bio Holdings financials performed over time
TVGN's total assets is 65% lower than its total liabilities
The company's quick ratio has surged by 50% QoQ and by 41% YoY
TVGN's current ratio is up by 35% since the previous quarter and by 30% year-on-year
The debt is 162% more than the equity
The debt has soared by 132% YoY and by 67% from the previous quarter
The debt to equity has shrunk by 72% YoY and by 44% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.